Trade Summary

3 days ago, Berkowitz Noah, serving as Chief Medical Officer at Arvinas, Inc. (ARVN), sold 11,108 shares at $9.94 per share, for a total transaction value of $110,385.00. Following this transaction, Berkowitz Noah now holds 191,395 shares of ARVN.

This sale represents a 5.00% decrease in Berkowitz Noah's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 11, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 13, 2026, 2 days after the trade was made.

Arvinas, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.